These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
588 related items for PubMed ID: 34560422
1. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages. Gunassekaran GR, Poongkavithai Vadevoo SM, Baek MC, Lee B. Biomaterials; 2021 Nov; 278():121137. PubMed ID: 34560422 [Abstract] [Full Text] [Related]
2. IL4 receptor targeting enables nab-paclitaxel to enhance reprogramming of M2-type macrophages into M1-like phenotype via ROS-HMGB1-TLR4 axis and inhibition of tumor growth and metastasis. Vadevoo SMP, Kang Y, Gunassekaran GR, Lee SM, Park MS, Jo DG, Kim SK, Lee H, Kim WJ, Lee B. Theranostics; 2024 Nov; 14(6):2605-2621. PubMed ID: 38646639 [Abstract] [Full Text] [Related]
3. Reprogramming tumor-associated macrophages using exosomes from M1 macrophages. Mahmoudi M, Taghavi-Farahabadi M, Hashemi SM, Mousavizadeh K, Rezaei N, Mojtabavi N. Biochem Biophys Res Commun; 2024 Nov 12; 733():150697. PubMed ID: 39288697 [Abstract] [Full Text] [Related]
4. IL4 Receptor-Targeted Proapoptotic Peptide Blocks Tumor Growth and Metastasis by Enhancing Antitumor Immunity. Vadevoo SMP, Kim JE, Gunassekaran GR, Jung HK, Chi L, Kim DE, Lee SH, Im SH, Lee B. Mol Cancer Ther; 2017 Dec 12; 16(12):2803-2816. PubMed ID: 28878029 [Abstract] [Full Text] [Related]
6. In vitro and in vivo evaluation of anti-tumoral effect of M1 phenotype induction in macrophages by miR-130 and miR-33 containing exosomes. Moradi-Chaleshtori M, Bandehpour M, Soudi S, Mohammadi-Yeganeh S, Hashemi SM. Cancer Immunol Immunother; 2021 May 12; 70(5):1323-1339. PubMed ID: 33140190 [Abstract] [Full Text] [Related]
7. Ferroptotic cardiomyocyte-derived exosomes promote cardiac macrophage M1 polarization during myocardial infarction. Sun S, Wu Y, Maimaitijiang A, Huang Q, Chen Q. PeerJ; 2022 May 12; 10():e13717. PubMed ID: 35818358 [Abstract] [Full Text] [Related]
8. Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line. Moradi-Chaleshtori M, Bandehpour M, Heidari N, Mohammadi-Yeganeh S, Mahmoud Hashemi S. Int Immunopharmacol; 2021 Jan 12; 90():107198. PubMed ID: 33249048 [Abstract] [Full Text] [Related]
9. In Situ Reprogramming of Tumor-Associated Macrophages with Internally and Externally Engineered Exosomes. Zhang L, Lin Y, Li S, Guan X, Jiang X. Angew Chem Int Ed Engl; 2023 Mar 06; 62(11):e202217089. PubMed ID: 36658634 [Abstract] [Full Text] [Related]
10. BMSCs-derived Exosome CISH Alleviates Myocardial Infarction by Inactivating the NF-κB Pathway to Stimulate Macrophage M2 Polarization. Ouyang M, Yang Y, Yu G, Zhao J, Peng Y. Cardiovasc Toxicol; 2024 Apr 06; 24(4):422-434. PubMed ID: 38512651 [Abstract] [Full Text] [Related]
11. Reprogramming tumor-associated macrophages by a dually targeted milk exosome system as a potent monotherapy for cancer. Chen Y, Gong L, Cao Y, Liu Z, Wang Y, Cheng H, Feng Y, Yao S, Yin Y, Wu Z, Huang Z. J Control Release; 2024 Feb 06; 366():395-409. PubMed ID: 38184235 [Abstract] [Full Text] [Related]
12. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis. Liu W, Long Q, Zhang W, Zeng D, Hu B, Liu S, Chen L. Aging (Albany NY); 2021 Aug 13; 13(15):19760-19775. PubMed ID: 34388111 [Abstract] [Full Text] [Related]
13. Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer. Kim H, Park HJ, Chang HW, Back JH, Lee SJ, Park YE, Kim EH, Hong Y, Kwak G, Kwon IC, Lee JE, Lee YS, Kim SY, Yang Y, Kim SH. Bioact Mater; 2023 Jul 13; 25():527-540. PubMed ID: 37056267 [Abstract] [Full Text] [Related]
14. Transfer of miRNA in tumor-derived exosomes suppresses breast tumor cell invasion and migration by inducing M1 polarization in macrophages. Moradi-Chaleshtori M, Shojaei S, Mohammadi-Yeganeh S, Hashemi SM. Life Sci; 2021 Oct 01; 282():119800. PubMed ID: 34245773 [Abstract] [Full Text] [Related]
15. Anti-Tumoral Effect and Action Mechanism of Exosomes Derived From Toxoplasma gondii-Infected Dendritic Cells in Mice Colorectal Cancer. Zhu S, Lu J, Lin Z, Abuzeid AMI, Chen X, Zhuang T, Gong H, Mi R, Huang Y, Chen Z, Li G. Front Oncol; 2022 Oct 01; 12():870528. PubMed ID: 35600340 [Abstract] [Full Text] [Related]
16. Mesenchymal stem cell exosomal tsRNA-21109 alleviate systemic lupus erythematosus by inhibiting macrophage M1 polarization. Dou R, Zhang X, Xu X, Wang P, Yan B. Mol Immunol; 2021 Nov 01; 139():106-114. PubMed ID: 34464838 [Abstract] [Full Text] [Related]
17. Comprehensive Integrative Analysis Reveals the Association of KLF4 with Macrophage Infiltration and Polarization in Lung Cancer Microenvironment. Arora S, Singh P, Ahmad S, Ahmad T, Dohare R, Almatroodi SA, Alrumaihi F, Rahmani AH, Syed MA. Cells; 2021 Aug 14; 10(8):. PubMed ID: 34440860 [Abstract] [Full Text] [Related]
18. Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer. Zhao Y, Zheng Y, Zhu Y, Li H, Zhu H, Liu T. J Nanobiotechnology; 2022 Aug 02; 20(1):359. PubMed ID: 35918698 [Abstract] [Full Text] [Related]
19. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization. Jang JY, Lee JK, Jeon YK, Kim CW. BMC Cancer; 2013 Sep 17; 13():421. PubMed ID: 24044575 [Abstract] [Full Text] [Related]
20. Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles. Chong L, Jiang YW, Wang D, Chang P, Xu K, Li J. J Nanobiotechnology; 2023 Oct 31; 21(1):401. PubMed ID: 37907987 [Abstract] [Full Text] [Related] Page: [Next] [New Search]